SEC Form 4 · accession 0001373894-19-000015
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Lerner
Officer — VP - Finance
Period of report
Mar 11, 2019
Accepted (ET)
Mar 13, 2019 · 3:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par ValueF1 | Mar 11, 2019 | S | 7,645 | $15.11 | D | 14,632 | D | |
| Common Stock, $.005 Par ValueF2 | Mar 12, 2019 | S | 1,412 | $15.06 | D | 13,220 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.30, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F2The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.93 to $15.25, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.